NEPHROS INC

NEPH

NEPHROS INC

NEPH

Insider Sentiment (TTM):

Last Purchase:2024-05-30Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:5,370,279Shares Outstanding:10,650,819Institutional Ownership Pct.:50.42%

Earnings Market Reaction:

Filing Date:2026-08-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	5	4	5	5	5	4	4	2	3	4	4	5
Accounts Receivable Net Current	4	4	2	3	2	3	2	2	2	2	1	1
Inventory Net	5	4	3	3	2	2	3	3	3	3	2	2
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	14	11	11	11	10	9	8	7	8	8	8	9
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Finite Lived Intangible Assets Net	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill	1	1	1	1	1	1	1	1	1	1	1	1
Indefinite Lived License Agreements	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	16	14	14	13	12	12	11	10	11	11	12	11
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	1	1	1	1	1	1	0	1	1	1	1
Accrued Liabilities Current	1	1	1	1	1	1	1	0	0	0	1	1
Liabilities Current	3	3	3	2	2	2	2	1	2	2	2	2
Liabilities	4	3	3	3	3	2	3	2	3	3	4	2
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	154	154	153	153	153	153	153	153	153	153	153	152
Retained Earnings Accumulated Deficit	-142	-143	-143	-143	-144	-144	-144	-145	-145	-145	-144	-144
Stockholders Equity	12	11	10	10	10	9	9	8	8	8	8	9
Liabilities And Stockholders Equity	16	14	14	13	12	12	11	10	11	11	12	11
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	40	40	40	40	40	40	40	40	40	40	40	40
Common Stock Shares Issued	11	11	11	11	11	11	11	11	11	11	11	10
Shares Outstanding	11	11	11	11	11	11	11	11	11	11	11	10

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	13.31%	11.76%	12.69%	-	-	-	-	-	-	-	-	-
2025	57.01%	88.32%	59.81%	29.07%	53.98%	80.97%	-6.15%	-5.19%	-10.00%	-24.47%	-18.16%	-3.68%
2024	-1.80%	-4.95%	-1.35%	-14.08%	-19.72%	-35.21%	1.90%	-2.53%	0.63%	31.58%	42.11%	154.61%
2023	-	-	-	-	-	-	9.95%	72.14%	78.11%	0.46%	1.38%	0.46%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.07	4.55	4.06	4.34	5.41	5.92	5.31	6.95	4.06	4.21	3.98	4.65
Quick Ratio	2.63	2.98	2.82	3.17	4.01	4.45	3.55	3.92	2.54	2.67	2.75	3.32
Working Capital	10.25M	8.97M	8.46M	8.24M	7.81M	7.47M	6.74M	6.30M	5.97M	6.20M	6.29M	6.68M
Leverage & Debt
Debt to Equity	0.32	0.29	0.34	0.32	0.28	0.27	0.31	0.27	0.40	0.40	0.42	0.27
Interest Coverage TTM	821.00	225.67	382.00	722.50	1,337.00	-	6.00	-480.00	-684.50	-743.50	-796.50	-96.29
Debt Ratio	0.24	0.22	0.25	0.24	0.22	0.21	0.23	0.21	0.29	0.28	0.30	0.21
Efficiency & Turnover
Asset Turnover TTM	1.48	1.50	1.51	1.52	1.43	1.34	1.23	1.27	1.28	1.26	1.25	1.22
Days Sales Outstanding TTM	54.04	59.15	40.75	44.30	42.86	49.34	42.23	42.22	45.78	45.17	35.66	37.97
Receivables Turnover TTM	6.75	6.17	8.96	8.24	8.52	7.40	8.64	8.64	7.97	8.08	10.24	9.61
Per Share Metrics
Diluted EPS TTM	0.16	0.07	0.11	0.13	0.12	0.08	0.01	-0.09	-0.12	-0.14	-0.15	-0.16
Free Cash Flow Per Share TTM	-0.06	-0.03	0.16	0.26	0.19	0.04	-0.05	-0.20	-0.09	-0.01	0.08	0.08
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	61.26%	59.95%	61.87%	63.24%	63.37%	62.45%	61.59%	61.04%	60.38%	60.31%	59.03%	58.38%
Operating Profit Margin TTM	7.92%	3.54%	6.10%	8.06%	8.01%	4.98%	0.04%	-7.09%	-9.94%	-10.57%	-11.19%	-12.09%
Net Profit Margin TTM	8.38%	4.06%	6.35%	8.26%	7.95%	5.16%	0.52%	-6.86%	-9.40%	-10.23%	-11.06%	-12.50%
Growth Metrics
Net Revenue Growth (1Y)	24.20%	23.25%	32.67%	32.36%	21.16%	10.34%	-0.53%	0.04%	12.79%	22.15%	42.74%	34.67%
Net Income Growth (1Y)	30.82%	-3.12%	1,513.51%	-259.42%	-202.55%	-155.70%	-104.70%	-45.09%	-72.71%	-73.59%	-77.84%	-77.25%
EPS Growth (1Y)	27.74%	-3.58%	1,500.27%	-258.40%	-201.67%	-155.18%	-104.64%	-45.53%	-73.26%	-74.10%	-78.03%	-77.59%
Valuation Metrics
P/E TTM	22.33	40.90	43.37	33.89	32.67	22.76	209.08	-19.41	-17.14	-15.99	-22.82	-9.15
P/B TTM	3.24	2.97	5.08	5.02	4.52	1.96	1.80	2.21	2.80	2.81	4.30	1.80
P/S TTM	1.87	1.66	2.76	2.80	2.60	1.18	1.09	1.33	1.61	1.64	2.52	1.14
Market Cap	38.76M	31.74M	51.79M	50.19M	43.36M	18.23M	15.47M	18.03M	22.18M	23.00M	35.94M	15.48M
Enterprise Value	34.06M	27.72M	46.39M	45.02M	38.28M	14.15M	11.71M	15.57M	19.10M	19.37M	31.63M	10.86M
Calculated Values
Free Cash Flow TTM	-661.00K	-348.00K	1.65M	2.72M	2.00M	447.00K	-547.00K	-2.09M	-903.00K	-121.00K	827.00K	869.00K
Net Debt	-4.70M	-4.02M	-5.40M	-5.17M	-5.07M	-4.08M	-3.76M	-2.46M	-3.08M	-3.63M	-4.31M	-4.62M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-05-30Purchase

Owner: Amron, Arthur H

Title: -

Shares: 3,000

Price/Share: $2.24

Value: $6,720.00

Shares Owned: 103,463

Relationship: Director

Ownership: Direct

2024-05-16Purchase

Owner: Banks, Robert R. Jr.

Title: President and CEO

Shares: 50,000

Price/Share: $2.24

Value: $112,000.00

Shares Owned: 70,000

Relationship: Director,Officer

Ownership: Direct

2024-03-12Purchase

Owner: Amron, Arthur H

Title: -

Shares: 7,000

Price/Share: $2.45

Value: $17,150.00

Shares Owned: 7,000

Relationship: Director

Ownership: Direct

2023-12-07Purchase

Owner: Banks, Robert R. Jr.

Title: President and CEO

Shares: 18,000

Price/Share: $2.20

Value: $39,600.00

Shares Owned: 20,000

Relationship: Director,Officer

Ownership: Direct

2023-08-15Purchase

Owner: Banks, Robert R. Jr.

Title: President and CEO

Shares: 1,901

Price/Share: $1.69

Value: $3,212.69

Shares Owned: 2,000

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-05-30	Amron, Arthur H	Director	-	Direct	Purchase	3,000	2.24	$6,720.00	103,463	4
2024-05-16	Banks, Robert R. Jr.	Director,Officer	President and CEO	Direct	Purchase	50,000	2.24	$112,000.00	70,000	4
2024-03-12	Amron, Arthur H	Director	-	Direct	Purchase	7,000	2.45	$17,150.00	7,000	4
2023-12-07	Banks, Robert R. Jr.	Director,Officer	President and CEO	Direct	Purchase	18,000	2.20	$39,600.00	20,000	4
2023-08-15	Banks, Robert R. Jr.	Director,Officer	President and CEO	Direct	Purchase	1,901	1.69	$3,212.69	2,000	4
2021-08-20	Lobo, Wesley S.	Officer	Chief Marketing Officer	Direct	Purchase	1,000	7.92	$7,920.00	41,557	4
2021-08-18	Astor, Andrew	Director,Officer	President & CEO	Direct	Purchase	2,500	7.77	$19,425.00	77,958	4
2021-08-18	Gwydir, Tom	Director	-	Direct	Purchase	5,000	7.64	$38,200.00	11,031	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

50.42%

Inst. Shares: 5,370,279

Shares Outstanding: 10,650,819

2025-12-31

49.31%

Inst. Shares: 5,233,200

Shares Outstanding: 10,612,288

2025-09-30

47.26%

Inst. Shares: 5,015,032

Shares Outstanding: 10,612,012

2025-06-30

45.77%

Inst. Shares: 4,852,137

Shares Outstanding: 10,600,409

2025-03-31

43.64%

Inst. Shares: 4,625,760

Shares Outstanding: 10,600,350

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	5,370,279	10,650,819	50.42%
2025-12-31	5,233,200	10,612,288	49.31%
2025-09-30	5,015,032	10,612,012	47.26%
2025-06-30	4,852,137	10,600,409	45.77%
2025-03-31	4,625,760	10,600,350	43.64%
2024-12-31	4,670,464	10,525,197	44.37%
2024-09-30	4,248,366	10,544,139	40.29%
2024-06-30	4,270,604	10,509,937	40.63%
2024-03-31	4,171,937	10,501,771	39.73%
2023-12-31	4,284,578	10,386,018	41.25%
2023-09-30	4,243,664	10,460,866	40.57%
2023-06-30	4,220,821	10,297,429	40.99%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

NEPHROS INC (NEPH) — SEC Financial Statements & Analysis

NEPHROS INC (NEPH) is a surgical & medical instruments & apparatus company, incorporated in DE. NEPHROS INC trades on Nasdaq as: NEPH. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), NEPHROS INC reported a 24.20% year-over-year revenue growth, a Gross Profit Margin of 61.26% (TTM), a Debt-to-Equity ratio of 0.32x, a Price-to-Sales (P/S) ratio of 1.87x (TTM), a Price-to-Book (P/B) ratio of 3.24x (TTM), at a market cap of $38.76M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 24.20%
Gross Profit Margin TTM: 61.26%
Debt To Equity: 0.32x
P/S TTM: 1.87x
P/B TTM: 3.24x
Market Cap: $38.76M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is NEPHROS INC in?

NEPHROS INC (NEPH) operates in the Surgical & Medical Instruments & Apparatus industry.

What is NEPH's market cap?

NEPHROS INC (NEPH) has a market capitalization of $38.76M as of 2026-06-30.

What is NEPH's P/E ratio?

NEPHROS INC (NEPH)'s trailing twelve month P/E ratio is 22.33x as of 2026-06-30.

What exchange does NEPH trade on?

NEPHROS INC (NEPH) trades on the Nasdaq.

Where is NEPHROS INC incorporated?

NEPHROS INC is incorporated in DE.

NEPHROS INC

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

NEPHROS INC (NEPH) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.
Main Street's price.

NEPHROS INC (NEPH) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.